<?xml version="1.0" encoding="UTF-8"?>
<p id="par0065">Emerging evidence suggests that SARS-CoV-2 has a tropism for myocardium and pericardium. Myocardial injury, detected by the presence of elevated high-sensitivity troponin I, has been reported to occur in about 12% of patients with COVID-19, and the virus has also been isolated in the pericardial fluid of a patient with COVID-19-associated pericarditis and cardiac tamponade (
 <xref rid="bib0020" ref-type="bibr">Farina et al., 2020</xref>, 
 <xref rid="bib0030" ref-type="bibr">Huang et al., 2020</xref>). However, previous reports are scarce and in the majority of cases pulmonary involvement in COVID-19 is dominant, accompanied by perimyocardial damage. In these patients, perimyocarditis was mainly diagnosed due to clinical deterioration caused by heart failure (
 <xref rid="bib0075" ref-type="bibr">Zeng et al., 2020</xref>, 
 <xref rid="bib0005" ref-type="bibr">Chen et al., 2020</xref>, 
 <xref rid="bib0010" ref-type="bibr">Cizgici et al., 2020</xref>, 
 <xref rid="bib0020" ref-type="bibr">Farina et al., 2020</xref>).
</p>
